Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum

Respiration

Volumn 74, Issue 1, 2006, Pages 19-25

  Roche, N ^a   Kouassi, B ^a   Rabbat, A ^a   Mounedji, A ^a   Lorut, C ^a   Huchon, G ^a  

^a HÔTEL DIEU   (France)

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Leukocyte count; Sputum microbiological examination

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN DERIVATIVE; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE EXACERBATION; EPITHELIUM CELL; FEMALE; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORAXELLA CATARRHALIS; OXYGEN THERAPY; PRIORITY JOURNAL; PSEUDOMONAS; SPUTUM ANALYSIS; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIA;

AGED; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INPATIENTS; LEUKOCYTE COUNT; MALE; PNEUMOCOCCAL INFECTIONS; PROGNOSIS; PROSPECTIVE STUDIES; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; STREPTOCOCCUS PNEUMONIAE; SUPPURATION;

EID: 33845760022     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093158     Document Type: Article

References (23)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
2. Strassels SA, Smith DH, Sullivan SD, Mahajan PS: The costs of treating COPD in the United States. Chest 2001;119:344-352.
3. Wilson L, Devine EB, So K: Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med 2000;94:204-213.
4. Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 2000;117:5S-9S.
5. Sethi S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000;117:380S-385S.
6. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H: Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998;113:1542-1548.
7. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M: Relationship between bacterial fl ora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999;116:40-46.
8. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852.
9. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001;164:358-364.
10. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764.
11. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA: Bronchiectasis, exacerbation indices and infl ammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:400-407.
12. Anthonisen NR, Manfreda J, Warren CPW, Hershfi eld ES, Harding GKM, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
13. Stockley RA, O'Brien C, Pye A, Hill SL: Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117:1638-1645.
14. Groenewegen KH, Wouters EF: Bacterial infections in patients requiring admission for an acute exacerbation of COPD: a 1-year prospective study. Respir Med 2003;97:770-777.
15. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(suppl 5):S1-S28.
16. Sociétéde Pneumologie de Langue Française. Recommandations pour la prise en charge de la bronchopneumopathie chronique obstructive. Rev Mal Respir 2003;20:294-329.
17. Bartlett JG, Finegold SM: Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis 1978;117:1019-1027.
18. Cooper GM, Jones JJ, Arbique JC, Flowerdew GJ, Forward KR: Intra and inter technologist variability in the quality assessment of respiratory tract specimens. Diagn Microbiol Infect Dis 2000;37:231-235.
19. Martin RS, Sumarah RK, Robart EM: Assessment of expectorated sputum for bacteriological analysis based on polymorphs and squamous epithelial cells: six-month study. J Clin Microbiol 1978;8:635-637.
20. Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C: Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 1977;6:396-399.
21. Schonheyder HC: Clinical microbiological study of sputum and aspirates from larynx or trachea. An evaluation of exact criteria for assessment by direct microscopy (in Danish). Ugeskr Laeger 1994;156:5703-5707.
22. Flournoy DJ, Davidson LJ: Sputum quality: can you tell by looking? Am J Infect Control 1993;21:64-69.
23. Ewig S, Schlochtermeier M, Goke N, Niederman MS: Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002;121:1486-1492.